Cytodyn Inc (CYDY)

[weasel6667]

Can you estimate a number what the uplisting and short-term costs would be?
One would/ could consider they have all ducks in a row and financing of the uplisting would not be a (or the) problem when they actually announce the Intention of a RS with the following uplisting. Did the financing deal bust in the last minute?

I would like to know if this slow death spiral (Paulson raises) has less risk than a proper prepared uplisting which other companies have also mastered in the past. In the opinion of management it seems so.